Published December 3, 2025 | Version v1

Formulation and Evaluation of Sustained-Release Matrix Tablets of Bethanechol Hydrochloride

Authors/Creators

Description

The objective of the present research was to design, formulate, and evaluate sustained-release (SR) matrix tablets of Bethanechol Hydrochloride to prolong therapeutic activity and minimize frequent dosing. Bethanechol HCl has a short biological half-life that limits therapeutic effectiveness. Six matrix formulations (F1–F6) were prepared using hydrophilic and hydrophobic polymers. Pre-formulation studies confirmed drug–excipient compatibility and good micrometric properties. Post-compression evaluation indicated compliance with pharmacopoeial limits. Among all formulations, F5 (HPMC 2208) provided optimal sustained-release behaviour with ~95% drug release in 24 hours. Kinetic modeling confirmed diffusion-controlled release following the Higuchi model. Stability studies indicated the robustness of the optimized formulation. The results support once-daily dosing and commercial feasibility of the SR matrix system.

Files

7-Research paper-Raman Singh.docx.pdf

Files (4.2 MB)

Name Size
md5:322b7d2965c1aa7c38ed0a8b871d1acd
4.2 MB Preview Download